Endogenous and Exogenous Opioids in Pain.

Opioids are the most commonly used and effective analgesic treatments for severe pain, but they have recently come under scrutiny owing to epidemic levels of abuse and overdose. These compounds act on the endogenous opioid system, which comprises four G protein-coupled receptors (mu, delta, kappa, and nociceptin) and four major peptide families (β-endorphin, enkephalins, dynorphins, and nociceptin/orphanin FQ). In this review, we first describe the functional organization and pharmacology of the endogenous opioid system. We then summarize current knowledge on the signaling mechanisms by which opioids regulate neuronal function and neurotransmission. Finally, we discuss the loci of opioid analgesic action along peripheral and central pain pathways, emphasizing the pain-relieving properties of opioids against the affective dimension of the pain experience.

[1]  H. Fields,et al.  Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla , 1992, Neuroscience.

[2]  N. Maidment,et al.  Constitutively Active Mu Opioid Receptors Mediate the Enhanced Conditioned Aversive Effect of Naloxone in Morphine-Dependent Mice , 2006, Neuropsychopharmacology.

[3]  R. Al-Hasani,et al.  Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics , 2015, The Journal of Neuroscience.

[4]  T. Yamamoto,et al.  Antagonism of ORLI receptor produces an algesic effect in the rat formalin test. , 2001, Neuroreport.

[5]  Henry Lin,et al.  Structure-based discovery of opioid analgesics with reduced side effects , 2016, Nature.

[6]  V. Durmaz,et al.  A nontoxic pain killer designed by modeling of pathological receptor conformations , 2017, Science.

[7]  Leonard J. Paulozzi,et al.  Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010 , 2013, MMWR. Morbidity and mortality weekly report.

[8]  M. Bruchas,et al.  Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by κ Opioid Activation of p38 Mitogen-Activated Protein Kinase , 2007, The Journal of Neuroscience.

[9]  Sara R. Jones,et al.  Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria , 2016, Science Signaling.

[10]  C. Inturrisi Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.

[11]  Kevin T. Beier,et al.  A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins , 2017, Neuron.

[12]  R. Gainetdinov,et al.  Enhanced morphine analgesia in mice lacking beta-arrestin 2. , 1999, Science.

[13]  M. Bruchas,et al.  Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase* , 2007, Journal of Biological Chemistry.

[14]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[15]  Alipasha Vaziri,et al.  A Guide to Emerging Technologies for Large-Scale and Whole-Brain Optical Imaging of Neuronal Activity. , 2018, Annual review of neuroscience.

[16]  P. Law,et al.  delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  M. Caron,et al.  Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance , 2004, The Journal of Neuroscience.

[18]  J. Kauer,et al.  Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress , 2017, eLife.

[19]  R. Luján,et al.  New insights into the therapeutic potential of Girk channels , 2014, Trends in Neurosciences.

[20]  E. E. Bagley,et al.  Endogenous opioids regulate moment-to-moment neuronal communication and excitability , 2017, Nature Communications.

[21]  Lee S. Simon RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH , 2012, Military medicine.

[22]  Laxmaiah Manchikanti,et al.  Opioid epidemic in the United States. , 2012, Pain physician.

[23]  C. Vaughan,et al.  Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance , 2017, The Journal of physiology.

[24]  M. von Zastrow,et al.  Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance , 2013, Pharmacological Reviews.

[25]  R. Al-Hasani,et al.  Molecular mechanisms of opioid receptor-dependent signaling and behavior. , 2011, Anesthesiology.

[26]  Katja Wiech,et al.  Deconstructing the sensation of pain: The influence of cognitive processes on pain perception , 2016, Science.

[27]  J. Levine,et al.  Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals , 2018, The Journal of Neuroscience.

[28]  T. Yaksh,et al.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective. , 2016, Annual review of pharmacology and toxicology.

[29]  Viviana Gradinaru,et al.  Viral Strategies for Targeting the Central and Peripheral Nervous Systems. , 2018, Annual review of neuroscience.

[30]  M. Stoffel,et al.  G-Protein-Gated Potassium Channels Containing Kir3.2 and Kir3.3 Subunits Mediate the Acute Inhibitory Effects of Opioids on Locus Ceruleus Neurons , 2002, The Journal of Neuroscience.

[31]  M. Bruchas,et al.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems , 2016, Pharmacological Reviews.

[32]  T. Kenakin,et al.  Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Michael Mousseau,et al.  Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents , 2017, Nature Medicine.

[34]  T. Vanderah,et al.  Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure , 2005, Biopolymers.

[35]  E. Navratilova,et al.  Behavioral and neurochemical analysis of ongoing bone cancer pain in rats , 2015, Pain.

[36]  Julia C. Lemos,et al.  The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System , 2008, The Journal of Neuroscience.

[37]  H. Loh,et al.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  C. Woolf,et al.  Inflammation-induced decrease in voluntary wheel running in mice: A nonreflexive test for evaluating inflammatory pain and analgesia , 2012, PAIN®.

[39]  Marc G Caron,et al.  Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice , 2003, The Journal of Neuroscience.

[40]  M. Bruchas,et al.  Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria , 2007, The Journal of Neuroscience.

[41]  M. von Zastrow,et al.  GPCR signaling along the endocytic pathway. , 2014, Current opinion in cell biology.

[42]  R. Gereau,et al.  Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward , 2007, Proceedings of the National Academy of Sciences.

[43]  Elyssa B. Margolis,et al.  Understanding opioid reward , 2015, Trends in Neurosciences.

[44]  T. Vanderah Delta and Kappa Opioid Receptors as Suitable Drug Targets for Pain , 2010, The Clinical journal of pain.

[45]  Xiaoping Zhou,et al.  Identifying local and descending inputs for primary sensory neurons. , 2015, The Journal of clinical investigation.

[46]  W. Maixner,et al.  μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids , 2015, Progress in Neuro-psychopharmacology and Biological Psychiatry.

[47]  M. Bruchas,et al.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling , 2010, Proceedings of the National Academy of Sciences.

[48]  R. Stevens,et al.  Structure of the human k-opioid receptor in complex with JDTic , 2012 .

[49]  G. Pasternak Faculty Opinions recommendation of Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. , 2017 .

[50]  I. Vetter,et al.  The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway , 2006, Molecular pain.

[51]  J. Violin,et al.  Biased mu‐opioid receptor ligands: a promising new generation of pain therapeutics , 2017, Current opinion in pharmacology.

[52]  T. Kaneko,et al.  Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord , 2014, Neuron.

[53]  B. Morgan,et al.  Enkephalin. Synthesis of two pentapeptides isolated from porcine brain with receptor-mediated opiate agonist activity. , 1976, Journal of the Chemical Society. Perkin transactions 1.

[54]  P. Phillips,et al.  Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase , 2017, Nature Communications.

[55]  Michael M. Halassa,et al.  Toward an Integrative Theory of Thalamic Function. , 2018, Annual review of neuroscience.

[56]  A. Craig A new view of pain as a homeostatic emotion , 2003, Trends in Neurosciences.

[57]  D. Filliol,et al.  Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia , 2011, PAIN.

[58]  S. Linnarsson,et al.  Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing , 2014, Nature Neuroscience.

[59]  Masahiko Watanabe,et al.  A quantitative study of neurochemically defined populations of inhibitory interneurons in the superficial dorsal horn of the mouse spinal cord , 2017, Neuroscience.

[60]  F. Bloom,et al.  β-Endorphin: cellular localization, electrophysiological and behavioral effects , 1979 .

[61]  L. Bohn,et al.  Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor. , 2017, ACS medicinal chemistry letters.

[62]  Alison L. Barth,et al.  Generation of a KOR‐Cre knockin mouse strain to study cells involved in kappa opioid signaling , 2016, Genesis.

[63]  J. Pintar,et al.  Developmental Expression of the μ, κ, and δ Opioid Receptor mRNAs in Mouse , 1998, The Journal of Neuroscience.

[64]  R. Dolle,et al.  Peripherally restricted opioid agonists as novel analgesic agents. , 2004, Current pharmaceutical design.

[65]  G. Scherrer,et al.  Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons. , 2017, Handbook of experimental pharmacology.

[66]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[67]  F. Medzihradsky,et al.  Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. , 1984, Biochemical and biophysical research communications.

[68]  D. Filliol,et al.  Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout Mice , 2013, PloS one.

[69]  P. Fuchs,et al.  Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system , 2006, Experimental Neurology.

[70]  H. Loh,et al.  Immunofluorescent identification of a delta (delta)-opioid receptor on primary afferent nerve terminals. , 1993, Neuroreport.

[71]  V. Pickel,et al.  Ultrastructural Immunocytochemical Localization of μ-Opioid Receptors in Rat Nucleus Accumbens: Extrasynaptic Plasmalemmal Distribution and Association with Leu5-Enkephalin , 1996, The Journal of Neuroscience.

[72]  H. Akil,et al.  Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding , 1999, The Journal of comparative neurology.

[73]  A. Basbaum,et al.  Delta Opioid Receptors Presynaptically Regulate Cutaneous Mechanosensory Neuron Input to the Spinal Cord Dorsal Horn , 2014, Neuron.

[74]  J. Sandkühler,et al.  Erasure of a Spinal Memory Trace of Pain by a Brief, High-dose , 2022 .

[75]  D. Dodick,et al.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention , 2017, Cephalalgia : an international journal of headache.

[76]  Jonathan R. Tomshine,et al.  Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.

[77]  G. Koob,et al.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence‐induced hyperalgesia , 2015, Addiction biology.

[78]  H. Fields,et al.  Endogenous Opioid Activity in the Anterior Cingulate Cortex Is Required for Relief of Pain , 2015, The Journal of Neuroscience.

[79]  L. Bohn,et al.  Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance , 2011, Pharmacological Reviews.

[80]  Wei Chen,et al.  Differential regulation and properties of MAPKs , 2007, Oncogene.

[81]  G. Pasternak,et al.  Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene , 2014, Pain.

[82]  M. Nooh,et al.  Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks. , 2017, Cellular signalling.

[83]  C. Chavkin Dynorphin–Still an Extraordinarily Potent Opioid Peptide , 2013, Molecular Pharmacology.

[84]  S. Schulz,et al.  Targeting multiple opioid receptors – improved analgesics with reduced side effects? , 2018, British journal of pharmacology.

[85]  V. Pickel,et al.  Ultrastructural relationship between N-methyl-d-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala , 2009, Neuroscience.

[86]  Aaron M. Beedle,et al.  ORL1 receptor–mediated internalization of N-type calcium channels , 2006, Nature Neuroscience.

[87]  J. Manzanares,et al.  Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice , 2017, Neuropharmacology.

[88]  P. Prather,et al.  Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. , 2001, Molecular pharmacology.

[89]  T. Vanderah,et al.  Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance , 2001, The Journal of Neuroscience.

[90]  K. Berridge,et al.  Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting” , 2014, The Journal of Neuroscience.

[91]  J. Zubieta,et al.  Placebo effects on human μ-opioid activity during pain , 2007, Proceedings of the National Academy of Sciences.

[92]  N. Ling,et al.  beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[93]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[94]  Qingmin Chen,et al.  Pronociceptive actions of dynorphin via bradykinin receptors , 2008, Neuroscience Letters.

[95]  C. Büchel,et al.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.

[96]  L. Iversen,et al.  Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum , 1976, Nature.

[97]  H. Fields,et al.  Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons , 1986, Brain Research.

[98]  R. Adan,et al.  Morphine Withdrawal Enhances Constitutive μ-Opioid Receptor Activity in the Ventral Tegmental Area , 2012, The Journal of Neuroscience.

[99]  S. Mitra,et al.  Peripheral opioid receptor agonists for analgesia: a comprehensive review. , 2011, Journal of opioid management.

[100]  J. Gybels,et al.  Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain , 1991, Pain.

[101]  M. Olmstead,et al.  Neurobiology of Disease Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain , 2015 .

[102]  Sung Han,et al.  Elucidating an Affective Pain Circuit that Creates a Threat Memory , 2015, Cell.

[103]  J Lötsch,et al.  Differential Opioid Action on Sensory and Affective Cerebral Pain Processing , 2008, Clinical pharmacology and therapeutics.

[104]  Bryan L. Roth,et al.  Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.

[105]  F. Bloom,et al.  beta-endorphin: cellular localization, electrophysiological and behavioral effects. , 1978, Advances in biochemical psychopharmacology.

[106]  Xin-Qiu Yao,et al.  Dynamic Coupling and Allosteric Networks in the α Subunit of Heterotrimeric G Proteins* , 2015, The Journal of Biological Chemistry.

[107]  M. Olmstead,et al.  Changes in morphine reward in a model of neuropathic pain , 2013, Behavioural pharmacology.

[108]  A Thomas McLellan,et al.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. , 2016, The New England journal of medicine.

[109]  H. Fields,et al.  Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry , 2012, Proceedings of the National Academy of Sciences.

[110]  George L. Wilcox,et al.  Peripheral mechanisms of pain and analgesia , 2009, Brain Research Reviews.

[111]  P. Schwartzkroin,et al.  Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[112]  B. Zou,et al.  Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization , 2015, The Journal of Neuroscience.

[113]  T. Hales,et al.  - Arrestin 2 and c-Src Regulate the Constitutive Activity and Recycling of Opioid Receptors in Dorsal Root Ganglion Neurons , 2007 .

[114]  J. Streicher,et al.  Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications , 2017, Journal of pharmacy practice.

[115]  F. Simonin,et al.  Opioid-induced hyperalgesia: Cellular and molecular mechanisms , 2016, Neuroscience.

[116]  P. Lu,et al.  The persistence of a long-term negative affective state following the induction of either acute or chronic pain , 2008, PAIN.

[117]  S. W. Emmons,et al.  Neural Circuits of Sexual Behavior in Caenorhabditis elegans. , 2018, Annual review of neuroscience.

[118]  G. Pasternak,et al.  μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla , 1994, Brain Research.

[119]  Nathan A Baertsch,et al.  The Dynamic Basis of Respiratory Rhythm Generation: One Breath at a Time. , 2018, Annual review of neuroscience.

[120]  A. Basbaum,et al.  Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits , 2018, Neuron.

[121]  Long-chuan Yu,et al.  Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats , 2008, Regulatory Peptides.

[122]  S. Aicher,et al.  μ-Opioid Receptors Often Colocalize with the Substance P Receptor (NK1) in the Trigeminal Dorsal Horn , 2000, The Journal of Neuroscience.

[123]  M. Bruchas,et al.  Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* , 2006, Journal of Biological Chemistry.

[124]  Thomas E. Nichols,et al.  Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.

[125]  Julia C. Lemos,et al.  Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction , 2011, Neuron.

[126]  D. Price,et al.  A psychophysical analysis of morphine analgesia , 1985, Pain.

[127]  Nicole A. Crowley,et al.  Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward , 2015, Neuron.

[128]  Wendy M. Knowlton,et al.  Identification of Spinal Circuits Transmitting and Gating Mechanical Pain , 2014, Cell.

[129]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[130]  G. Piñeyro,et al.  Kir3 channel signaling complexes: focus on opioid receptor signaling , 2014, Front. Cell. Neurosci..

[131]  L. Bohn,et al.  Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics , 2017, Cell.

[132]  J. Traynor,et al.  Opioid receptor interacting proteins and the control of opioid signaling. , 2014, Current pharmaceutical design.

[133]  R. Palmiter,et al.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking , 2009, Proceedings of the National Academy of Sciences.

[134]  E. Stuenkel,et al.  κ-Opioid Receptor Activation Modulates Ca2+Currents and Secretion in Isolated Neuroendocrine Nerve Terminals , 1997, The Journal of Neuroscience.

[135]  J. Levine,et al.  Shared Mechanisms for Opioid Tolerance and a Transition to Chronic Pain , 2010, The Journal of Neuroscience.

[136]  A. Light,et al.  Hyperpolarization of substantia gelatinosa neurons evoked by μ-, κ-, δ1-, and δ2-selective opioids , 2002 .

[137]  D. Filliol,et al.  Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice , 2002, Brain Research.

[138]  S. Snyder,et al.  Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors. , 1978, Life sciences.

[139]  J. Sandkühler,et al.  Induction of Synaptic Long-Term Potentiation After Opioid Withdrawal , 2009, Science.

[140]  R. Kandasamy,et al.  The pharmacology of nociceptor priming. , 2015, Handbook of experimental pharmacology.

[141]  M. Low,et al.  Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.

[142]  M. Morgan,et al.  Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats , 2005, Neuroscience.

[143]  L. Hood,et al.  Dynorphin-(1-13), an extraordinarily potent opioid peptide. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[144]  A. Basbaum,et al.  Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain , 2009, Cell.

[145]  G. Pasternak Mu Opioid Pharmacology: 40 Years to the Promised Land. , 2018, Advances in pharmacology.

[146]  M. Bruchas,et al.  Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala , 2016, The Journal of Neuroscience.

[147]  A. Basbaum,et al.  Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Jürgen Sandkühler,et al.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy , 2011, Molecular pain.

[149]  D. Storm,et al.  Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence , 2013, Science.

[150]  Terence D Sanger Basic and Translational Neuroscience of Childhood-Onset Dystonia: A Control-Theory Perspective. , 2018, Annual review of neuroscience.

[151]  C. Chavkin,et al.  Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons* , 2006, Journal of Biological Chemistry.

[152]  Benedikt Zott,et al.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.

[153]  H. Pan,et al.  Opioid-Induced Long-Term Potentiation in the Spinal Cord Is a Presynaptic Event , 2010, The Journal of Neuroscience.

[154]  K. Palczewski,et al.  Designing Safer Analgesics via μ-Opioid Receptor Pathways. , 2017, Trends in pharmacological sciences.

[155]  A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks , 2014, Brain Structure and Function.

[156]  Zhen-Zhong Xu,et al.  β-arrestin-2 regulates NMDA receptor function in spinal lamina II neurons and duration of persistent pain , 2016, Nature Communications.

[157]  T. Prisinzano,et al.  Kappa opioids and the modulation of pain , 2010, Psychopharmacology.

[158]  B. Schmidt,et al.  Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling , 2015, Scientific Reports.

[159]  H. Sakamoto,et al.  MOR‐1‐immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P‐containing primary afferents and for selective activation by noxious thermal stimuli , 2002, The European journal of neuroscience.

[160]  M. Bruchas,et al.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors , 2010, Brain Research.

[161]  M. Bruchas,et al.  Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors , 2015, The Journal of Neuroscience.

[162]  H. Fields,et al.  Opioid peptides (DAGO-enkephalin, dynorphin A(1–13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla , 1989, Brain Research.

[163]  M. Angst,et al.  Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations , 2008, The Clinical journal of pain.

[164]  Nicole A. Crowley,et al.  Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit. , 2016, Cell reports.

[165]  M. Morgan,et al.  Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat , 2006, Pharmacology Biochemistry and Behavior.

[166]  L. Devi,et al.  Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities , 2015, British journal of pharmacology.

[167]  B. Kieffer,et al.  Opioid receptors: From binding sites to visible molecules in vivo , 2009, Neuropharmacology.

[168]  G. Stuber,et al.  Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior , 2017, eLife.

[169]  M. Narita,et al.  Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State , 2005, Neuropsychopharmacology.

[170]  L. Gendron,et al.  Recent advances on the δ opioid receptor: from trafficking to function , 2015, British journal of pharmacology.

[171]  H. Ueda Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. , 2006, Pharmacology & therapeutics.

[172]  Bernardo L. Sabatini,et al.  Photoactivatable Neuropeptides for Spatiotemporally Precise Delivery of Opioids in Neural Tissue , 2012, Neuron.

[173]  E. E. Bagley,et al.  β‐Arrestin‐2 knockout prevents development of cellular μ‐opioid receptor tolerance but does not affect opioid‐withdrawal‐related adaptations in single PAG neurons , 2015, British journal of pharmacology.

[174]  T. Hales,et al.  β-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of μ Opioid Receptors in Dorsal Root Ganglion Neurons , 2007, The Journal of Neuroscience.

[175]  H. Pan,et al.  Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of δ-opioid agonists on mechano-nociception , 2008, Neuropharmacology.

[176]  A. Duggan Neuropeptide spread in the brain and spinal cord. , 2000, Progress in brain research.

[177]  L. Becerra,et al.  fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. , 2004, Journal of neurophysiology.

[178]  J. Levine,et al.  Contribution of supraspinal μ- and δ-opioid receptors to antinociception in the rat , 1991 .

[179]  Aashish Manglik,et al.  Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.

[180]  Ian R. Wickersham,et al.  A Circuit Mechanism for Differentiating Positive and Negative Associations , 2015, Nature.

[181]  M. von Zastrow,et al.  β-arrestin drives MAP kinase signaling from clathrin-coated structures after GPCR dissociation , 2016, Nature Cell Biology.

[182]  R. Neve,et al.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway , 2018, Proceedings of the National Academy of Sciences.

[183]  M. Bruchas,et al.  Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits. , 2017, Current opinion in pharmacology.

[184]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[185]  C. Chavkin,et al.  Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[186]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.